Fundraising Fox

Prognos

Founded 2010 · 54 employees on LinkedIn · 7 known investors

Prognos builds a healthcare analytics platform that fuses clinical lab results with other patient-journey data to create unified patient views for life sciences companies. It focuses on rare disease and oncology, supporting patient identification, targeting, segmentation, and commercial decision-making.

AI & Machine LearningData & InfrastructureDigital HealthHealthtech

Founders & leadership

Prognos was founded in 2010 by Sundeep Bhan.

SBSundeep Bhan
Sundeep BhaninFounder

Investors · 7

Hikma VenturesLondon · $5M
Maywic Select InvestmentsCincinnati · $500K – $2.5M
Montage CapitalCampbell · $500K – $5M
Partners for GrowthTiburon · $1M – $50M
Partners for Growth (PFG)
Red & Blue VenturesPhiladelphia · $250K
Merck Global Health Innovation Fundreported · 2 sourcesRahway

In the news

What is Brief History of Prognos Health Company? – businessmodelcanvastemplate.combusinessmodelcanvastemplate.com · Jul 2024Prognos Health Raises $23 Million to Accelerate the Transformation of Healthcare Through Real-World Data Marketplacefinance.yahoo.com · May 2023Prognos raises $20.5 million from investors including Cigna, Merck Global Health Innovation Fund - MedCity Newsmedcitynews.com · Dec 2017Prognos Raises $20.5 Million in Series C Funding | 360Dx360dx.com · Nov 2017Prognos, Healthcare AI Company, Raises $20.5 Million Towards Predicting Disease the Earliestglobenewswire.com · Nov 2017

Frequently asked questions

What does Prognos do?
Prognos builds a healthcare analytics platform that fuses clinical lab results with other patient-journey data to create unified patient views for life sciences companies. It focuses on rare disease and oncology, supporting patient identification, targeting, segmentation, and commercial decision-making.
Who founded Prognos?
Prognos was founded by Sundeep Bhan in 2010.
Who are Prognos's investors?
Prognos's investors include Hikma Ventures, Maywic Select Investments, Montage Capital, Partners for Growth, Partners for Growth (PFG), Red & Blue Ventures, Merck Global Health Innovation Fund.